David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
CALL
Analog Devices
ADI
$180B
| $1.8M | ﹤0.01% |
28,600
-11,900
| -29% | -$675K |
|
|
MHFI
2077
PUT
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $1.8M | ﹤0.01% |
17,400
-20,100
| -54% | -$1.97M |
|
2078
CGI
GIB
$15.2B
| $1.79M | ﹤0.01% |
42,200
+19,835
| +89% | +$812K |
|
|
RDS.A
2079
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.79M | ﹤0.01% |
32,119
+10,706
| +50% | +$634K |
|
|
EMC
2080
CALL
DELISTED
EMC CORPORATION
EMC
| $1.79M | ﹤0.01% |
70,000
| – | – |
|
2081
Simpson Manufacturing
SSD
$7.58B
| $1.78M | ﹤0.01% |
47,740
+21,499
| +82% | +$755K |
|
2082
CALL
Stratasys
SSYS
$694M
| $1.78M | ﹤0.01% |
33,800
-15,600
| -32% | -$1.03M |
|
|
AHRT
2083
AH Realty Trust
AHRT
$501M
| $1.78M | ﹤0.01% |
167,198
-38,321
| -19% | -$404K |
|
2084
Plains GP Holdings
PAGP
$5.57B
| $1.78M | ﹤0.01% |
23,572
-34,818
| -60% | -$2.53M |
|
|
SUNE
2085
PUT
DELISTED
SUNEDISON, INC COM
SUNE
| $1.78M | ﹤0.01% |
74,200
-203,600
| -73% | -$4.38M |
|
2086
Bio-Rad Laboratories Class A
BIO
$10.4B
| $1.78M | ﹤0.01% |
13,145
-4,765
| -27% | -$591K |
|
|
LHO
2087
DELISTED
LaSalle Hotel Properties
LHO
| $1.77M | ﹤0.01% |
45,666
-166,050
| -78% | -$6.7M |
|
2088
CALL
Southern Company
SO
$103B
| $1.77M | ﹤0.01% |
40,000
-70,000
| -64% | -$3.33M |
|
|
EGIO
2089
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.77M | ﹤0.01% |
12,195
+2,803
| +30% | +$355K |
|
|
FCRD
2090
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $1.77M | ﹤0.01% |
144,133
+106,107
| +279% | +$1.24M |
|
|
AVTA
2091
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.77M | ﹤0.01% |
129,556
-58,571
| -31% | -$817K |
|
2092
PUT
Universal Health Services
UHS
$10.5B
| $1.77M | ﹤0.01% |
15,000
-20,000
| -57% | -$2.21M |
|
2093
ORIX
IX
$43.2B
| $1.76M | ﹤0.01% |
125,470
-34,470
| -22% | -$451K |
|
2094
Wolverine World Wide
WWW
$1.65B
| $1.76M | ﹤0.01% |
+52,663
| New | +$1.56M |
|
2095
Silgan Holdings
SLGN
$4.54B
| $1.76M | ﹤0.01% |
+60,594
| New | +$1.68M |
|
2096
The Greenbrier Companies
GBX
$1.43B
| $1.76M | ﹤0.01% |
+30,311
| New | +$1.68M |
|
2097
PUT
Ambarella
AMBA
$3.05B
| $1.76M | ﹤0.01% |
23,200
-5,500
| -19% | -$334K |
|
|
XXIA
2098
DELISTED
Ixia
XXIA
| $1.75M | ﹤0.01% |
144,673
+77,885
| +117% | +$864K |
|
2099
PUT
FirstEnergy
FE
$27B
| $1.75M | ﹤0.01% |
50,000
-20,000
| -29% | -$748K |
|
|
FENG
2100
Phoenix New Media
FENG
$17.8M
| $1.75M | ﹤0.01% |
51,539
-231
| -0.4% | -$10.1K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $2.47B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.